$ALMS SEC Filings

Filed On	Filing
09 Sep 2026	Form 4: Akkaraju Srinivas, Director Bought 440,140 shares ($4.92M) · Sold 96,131 shares ($1.01M) · Bought 546,581 shares ($5.81M)
01 Sep 2026	8-K: Other Events
17 Aug 2026	SCHEDULE 13D
13 Aug 2026	10-Q
13 Aug 2026	8-K: Results of Operations and Financial Condition
10 Aug 2026	8-K: Other Events
06 Aug 2026	SCHEDULE 13G
05 Aug 2026	Form 4: Schroer John R., Chief Financial Officer Sold 3,282 shares ($86.5K)
05 Aug 2026	Form 4: Pangali Sanam, Chief Legal Officer Sold 1,364 shares ($36K)
05 Aug 2026	Form 4: Hardiman Roy C., Chief Business & Strategy Ofcr Sold 2,692 shares ($71K)
05 Aug 2026	Form 4: Goldstein David M, Chief Scientific Officer Sold 2,596 shares ($68.5K)
05 Aug 2026	Form 4: Drappa Jorn, Chief Medical Officer Sold 2,447 shares ($64.5K)
05 Aug 2026	Form 4: Bradley Mark Christopher, Chief Development Officer Sold 2,572 shares ($67.8K)
27 Jul 2026	SCHEDULE 13G
08 Jul 2026	Form 4: Pangali Sanam, Chief Legal Officer Received 5,000 shares by exercise or conversion ($25.3K) · Sold 5,000 shares ($140K)
06 Jul 2026	144
02 Jul 2026	Form 4: Tetrault Lynn A., Director Received 3,553 shares as a grant or award · Granted 15,528 Stock Option (Right to Buy)
02 Jul 2026	Form 4: Yao Zhengbin, Director Received 3,553 shares as a grant or award · Granted 15,528 Stock Option (Right to Buy)
02 Jul 2026	Form 4: Srivastava Sapna, Director Received 3,553 shares as a grant or award · Granted 15,528 Stock Option (Right to Buy)
02 Jul 2026	Form 4: Machado Patrick, Director Received 3,553 shares as a grant or award · Granted 15,528 Stock Option (Right to Buy)

Comments